ELISA News and Research

RSS

Study using circulating spike protein and macrophage dysregulation liquid biomarkers reveals heterogeneity in PASC

In a new study, researchers designed a liquid biomarker panel consisting of macrophage and monocyte-related soluble factors and circulating spike proteins to understand profiles of immune dysregulation in patients with post-acute sequelae of COVID-19.

22 Sep 2022

What is the efficacy of aerosol treatment for SARS-CoV-2 infection?

In a new study, researchers assessed the efficacy of the scFv76 antibody against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lung damage.

21 Sep 2022

Why fatigue from long COVID goes beyond simply feeling tired

In a recent study posted to the medRxiv* preprint server, researchers in the Netherlands examined the role of inflammatory genes, cytotoxic T-lymphocytes (CD8+ T cells), and pro-inflammatory cytokines in long-lasting severe fatigue experienced by a large number of coronavirus disease 2019 (COVID-19) patients.

21 Sep 2022

New device for diagnosing bone fragility approved for marketing in the Europe

A new device for diagnosing bone fragility invented by the University Hospitals of Geneva and the University of Geneva has been approved for marketing in the European Economic Area and Switzerland.

20 Sep 2022

An improved COVID-19 vaccine shows promise against Omicron in experimental models

In a recent study published in the journal Science Translational Medicine, researchers in the United States designed a bivalent coronavirus disease 2019 (COVID-19) vaccine on the messenger ribonucleic acid (mRNA) platform.

18 Sep 2022

University of Arkansas receives NIST award to improve palm-sized, low-cost and wireless COVID sensor

The National Institute of Standards and Technology, via an application from the RAPID Manufacturing Institute, awarded the University of Arkansas $699,604 to improve a Wi-Fi nano-biosensor that will be used in a palm-sized, low-cost and wireless SARS-COV-II detection system.

16 Sep 2022

ValitaCell joins Beckman Coulter Life Sciences

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, announces it has acquired ValitaCell Ltd., a biotechnology company that creates pioneering analytical products and technologies for the biopharmaceutical industry.

From Beckman Coulter Life Sciences 16 Sep 2022

Excessive smartphone use may lead to early puberty

Exposure to blue light via regular use of tablets and smartphones may alter hormone levels and increase the risk of earlier puberty, according to data from a rat study presented today at the 60th Annual European Society for Paediatric Endocrinology Meeting.

16 Sep 2022

Study reveals pan-antiviral properties of PDC-109 bovine seminal plasma protein

In a new study, researchers explored the antiviral activity of the bovine seminal plasma protein PDC-109 against various mammalian viruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

15 Sep 2022

Simple phone-based outreach strategy can help engage low-income smokers to try quitting tobacco

New findings published in Nicotine & Tobacco Research show a simple, but valuable approach can help engage low-income smokers to try quitting tobacco.

14 Sep 2022

Study highlights the efficacy of MVA-BN booster vaccination in inducing durable B cell memory responses against monkeypox

In a new study, researchers assessed the immunogenicity, safety, and booster-efficacy of the Modified Vaccinia virus Ankara-Bavarian Nordic (MVA-BN) vaccine currently being used for immunization against monkeypox.

14 Sep 2022

Parenteral-prime mucosal boost an effective strategy to protect against SARS-CoV-2

In a recent study published in the journal eBioMedicine, researchers in Denmark and Sweden administered a cationic liposome-adjuvanted severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein subunit vaccine as a subcutaneous (s.c.) prime-intranasal (i.n.) boost strategy to elicit mucosal immune responses among SARS-CoV-2-infected Syrian hamsters.

14 Sep 2022

Are antibodies induced by historic smallpox vaccination cross-reactive with the monkeypox virus?

esearchers measured the monkeypox virus-neutralizing antibodies produced by the vaccinia virus vaccine, modified vaccinia virus Ankara vaccine, and monkeypox virus to understand the efficacy of the MVA-Bavarian Nordic vaccine currently being used against monkeypox.

12 Sep 2022

ELISA News and Research

Study using circulating spike protein and macrophage dysregulation liquid biomarkers reveals heterogeneity in PASC

What is the efficacy of aerosol treatment for SARS-CoV-2 infection?

Why fatigue from long COVID goes beyond simply feeling tired

New device for diagnosing bone fragility approved for marketing in the Europe

An improved COVID-19 vaccine shows promise against Omicron in experimental models

University of Arkansas receives NIST award to improve palm-sized, low-cost and wireless COVID sensor

ValitaCell joins Beckman Coulter Life Sciences

Excessive smartphone use may lead to early puberty

Study reveals pan-antiviral properties of PDC-109 bovine seminal plasma protein

Simple phone-based outreach strategy can help engage low-income smokers to try quitting tobacco

Study highlights the efficacy of MVA-BN booster vaccination in inducing durable B cell memory responses against monkeypox

Parenteral-prime mucosal boost an effective strategy to protect against SARS-CoV-2

Are antibodies induced by historic smallpox vaccination cross-reactive with the monkeypox virus?

A direct side-by-side comparison of all available COVID-19 vaccines

The evolution of humoral immune responses over the course of Epstein-Barr virus infection

Techniques used for SARS-CoV-2 detection in body fluids

Plant production of nanobodies that neutralize the interaction between ACE2 receptor and SARS-CoV-2 spike protein

Alternative approaches to functional and phenotypic assays using multi-parameter flow cytometry

Novel P22-mAb based bELISA assay can help detect antibodies against African swine fever virus

The most recent evidence about phylogenesis, pathogenesis, prevention, and treatment for monkeypox

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News